Inogen Inc (INGN) stock
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 12/3068% below fair value
$5.63−0.06 (-1.05%)
Close on Nov 16, 2026Market cap $149.41MP/E –Yield –
Inogen EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Inogen's EPS for the twelve months ending Sep 30, 2026 was -$1.31. For fiscal 2025 it was -$0.86. The highest annual figure on record is $2.30 in fiscal 2018.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.86 | – |
| FY2024 | Dec 31, 2024 | -$1.52 | – |
| FY2023 | Dec 31, 2023 | -$4.42 | – |
| FY2022 | Dec 31, 2022 | -$3.67 | – |
| FY2021 | Dec 31, 2021 | -$0.28 | – |
| FY2020 | Dec 31, 2020 | -$0.27 | -128.7% |
| FY2019 | Dec 31, 2019 | $0.94 | -59.1% |
| FY2018 | Dec 31, 2018 | $2.30 | +139.6% |
| FY2017 | Dec 31, 2017 | $0.96 | -1.0% |
| FY2016 | Dec 31, 2016 | $0.97 | +73.2% |
| FY2015 | Dec 31, 2015 | $0.56 | +86.7% |
| FY2014 | Dec 31, 2014 | $0.30 | -55.9% |
| FY2013 | Dec 31, 2013 | $0.68 | – |
| FY2012 | Dec 31, 2012 | -$19.97 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.61 | – |
| Q2 FY2026 | Jun 30, 2026 | -$0.14 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.30 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.26 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.20 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.15 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.25 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.41 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.25 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.24 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.62 | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.14 | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.97 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.42 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.88 | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.47 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.42 | -179.2% |
| Q2 FY2022 | Jun 30, 2022 | -$0.15 | -168.2% |
| Q1 FY2022 | Mar 31, 2022 | -$0.62 | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.06 | – |
| Q3 FY2021 | Sep 30, 2021 | $0.53 | – |
| Q2 FY2021 | Jun 30, 2021 | $0.22 | +83.3% |
| Q1 FY2021 | Mar 31, 2021 | -$0.03 | – |
| Q4 FY2020 | Dec 31, 2020 | -$0.23 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.08 | -125.8% |
| Q2 FY2020 | Jun 30, 2020 | $0.12 | -73.3% |
| Q1 FY2020 | Mar 31, 2020 | -$0.07 | -129.2% |
| Q4 FY2019 | Dec 31, 2019 | -$0.06 | -113.6% |
| Q3 FY2019 | Sep 30, 2019 | $0.31 | -57.5% |
| Q2 FY2019 | Jun 30, 2019 | $0.45 | -30.8% |
| Q1 FY2019 | Mar 31, 2019 | $0.24 | -50.0% |
| Q4 FY2018 | Dec 31, 2018 | $0.44 | – |
| Q3 FY2018 | Sep 30, 2018 | $0.73 | +121.2% |
| Q2 FY2018 | Jun 30, 2018 | $0.65 | +71.1% |
| Q1 FY2018 | Mar 31, 2018 | $0.48 | +77.8% |
| Q4 FY2017 | Dec 31, 2017 | -$0.03 | -112.0% |
| Q3 FY2017 | Sep 30, 2017 | $0.33 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.38 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.27 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.25 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?